{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:22:30Z","timestamp":1792794150888,"version":"4.5.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T00:00:00Z","timestamp":1533686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s41380-018-0133-2","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T13:46:28Z","timestamp":1533735988000},"page":"936-951","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Protein misassembly and aggregation as potential convergence points for non-genetic causes of chronic mental illness"],"prefix":"10.1038","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5581-8828","authenticated-orcid":false,"given":"Nicholas J.","family":"Bradshaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Korth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,8]]},"reference":[{"key":"133_CR1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/schbul\/sbu016","volume":"40","author":"AG Cardno","year":"2014","unstructured":"Cardno AG, Owen MJ. Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder. Schizophr Bull. 2014;40:504\u201315.","journal-title":"Schizophr Bull"},{"key":"133_CR2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics Consortium.","year":"2014","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421\u20137.","journal-title":"Nature"},{"key":"133_CR3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ajmg.b.32550","volume":"174","author":"ML Bustamante","year":"2017","unstructured":"Bustamante ML, Herrera L, Gaspar PA, Nieto R, Maturana A, Villar MJ, et al. Shifting the focus toward rare variants in schizophrenia to close the gap from genotype to phenotype. Am J Med Genet B Neuropscyhiatr Genet. 2017;174:663\u201370.","journal-title":"Am J Med Genet B Neuropscyhiatr Genet"},{"key":"133_CR4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41588-018-0059-2","volume":"50","author":"AF Pardinas","year":"2018","unstructured":"Pardinas AF, Holmans P, Pocklington AJ, Escott-Price V, Ripke S, Carrera N, et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat Genet. 2018;50:381\u20139.","journal-title":"Nat Genet"},{"key":"133_CR5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/bmj.295.6600.681","volume":"295","author":"RM Murray","year":"1987","unstructured":"Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? Br J Med. 1987;295:681\u20132.","journal-title":"Br J Med"},{"key":"133_CR6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archpsyc.1987.01800190080012","volume":"44","author":"DR Weinberger","year":"1987","unstructured":"Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44:660\u20139.","journal-title":"Arch Gen Psychiatry"},{"key":"133_CR7","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/mp.2012.23","volume":"17","author":"JL Rapoport","year":"2012","unstructured":"Rapoport JL, Giedd JN, Gogtay N. Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry. 2012;17:1228\u201338.","journal-title":"Mol Psychiatry"},{"key":"133_CR8","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/nn.4399","volume":"19","author":"M Fromer","year":"2016","unstructured":"Fromer M, Roussos P, Sieberts SK, Johnson JS, Kavanagh DH, Perumal TM, et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci. 2016;19:1442\u201353.","journal-title":"Nat Neurosci"},{"issue":"3 Suppl 2","key":"133_CR9","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1097\/00002093-200607001-00010","volume":"20","author":"Y Stern","year":"2006","unstructured":"Stern Y. Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord. 2006;20(3 Suppl 2):S69\u201374.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"133_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature12929","volume":"506","author":"M Fromer","year":"2014","unstructured":"Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, et al. De novo mutations in schizophrenia implicate synaptic networks. Nature. 2014;506:179\u201384.","journal-title":"Nature"},{"key":"133_CR11","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1126\/science.1067122","volume":"296","author":"JP Taylor","year":"2002","unstructured":"Taylor JP, Hardy J, Fischbeck KH. Toxic proteins in neurodegenerative disease. Science. 2002;296:1991\u20135.","journal-title":"Science"},{"key":"133_CR12","first-page":"177","volume":"30","author":"A Alzheimer","year":"1907","unstructured":"Alzheimer A. \u00dcber eine eigenartige Erkrankung der Hirnrinde. Cent Nerv Psychiatr. 1907;30:177\u20139.","journal-title":"Cent Nerv Psychiatr"},{"key":"133_CR13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF02866241","volume":"4","author":"A Alzheimer","year":"1911","unstructured":"Alzheimer A. \u00dcber eigenartige Krankheitsf\u00e4lle des sp\u00e4teren Alters. Z Ges Neurol Psychiatr. 1911;4:356\u201385.","journal-title":"Z Ges Neurol Psychiatr"},{"key":"133_CR14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.31887\/DCNS.2003.5.1\/hhippius","volume":"5","author":"H Hippius","year":"2003","unstructured":"Hippius H, Neundorfer G. The discovery of Alzheimer\u2019s disease. Dialogues Clin Neurosci. 2003;5:101\u20138.","journal-title":"Dialogues Clin Neurosci"},{"key":"133_CR15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211.","journal-title":"Neurobiol Aging"},{"key":"133_CR16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropath. 1991;82:239\u201359.","journal-title":"Acta Neuropath"},{"key":"133_CR17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tcb.2013.09.002","volume":"24","author":"D Vilchez","year":"2014","unstructured":"Vilchez D, Simic MS, Dillin A. Proteostasis and aging of stem cells. Trends Cell Biol. 2014;24:161\u201370.","journal-title":"Trends Cell Biol"},{"key":"133_CR18","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/jcmm.12349","volume":"18","author":"M Polajnar","year":"2014","unstructured":"Polajnar M, \u017derovnik E. Impaired autophagy: a link between neurodegenerative and neuropsychiatric diseases. J Cell Mol Med. 2014;18:1705\u201311.","journal-title":"J Cell Mol Med"},{"key":"133_CR19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.3457","volume":"20","author":"JL Guo","year":"2014","unstructured":"Guo JL, Lee VMY. Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med. 2014;20:130\u20138.","journal-title":"Nat Med"},{"key":"133_CR20","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJM200105173442006","volume":"344","author":"SB Prusiner","year":"2001","unstructured":"Prusiner SB. Shattuck Lecture -- neurodegenerative diseases and prions. N Engl J Med. 2001;344:1516\u201326.","journal-title":"N Engl J Med"},{"key":"133_CR21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","volume":"68","author":"L Bertram","year":"2010","unstructured":"Bertram L, Lill CM, Tanzi RE. The genetics of Alzheimer disease: back to the future. Neuron. 2010;68:270\u201381.","journal-title":"Neuron"},{"key":"133_CR22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.expneurol.2007.06.018","volume":"208","author":"K Uryu","year":"2007","unstructured":"Uryu K, Chen X-H, Martinez D, Browne KD, Johnson VE, Graham DI, et al. Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp Neurol. 2007;208:185\u201392.","journal-title":"Exp Neurol"},{"key":"133_CR23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1750-3639.2011.00513.x","volume":"22","author":"VE Johnson","year":"2012","unstructured":"Johnson VE, Stewart W, Smith DH. Widespread tau and amyloid-beta pathology many years after a single traumatic brain injury in humans. Brain Pathol. 2012;22:142\u20139.","journal-title":"Brain Pathol"},{"key":"133_CR24","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jamaneurol.2016.1948","volume":"73","author":"PK Crane","year":"2016","unstructured":"Crane PK, Gibbons LE, Dams-O\u2019Connor K, Trittschuh E, Leverenz JB, Keene CD, et al. Association of traumatic brain injury with late-life neurodegenerative conditions and neuropathologic findings. JAMA Neurol. 2016;73:1062\u20139.","journal-title":"JAMA Neurol"},{"key":"133_CR25","doi-asserted-by":"crossref","first-page":"18210","DOI":"10.1016\/S0021-9258(19)37174-1","volume":"267","author":"T Dyrks","year":"1992","unstructured":"Dyrks T, Dyrks E, Hartmann T, Masters C, Beyreuther K. Amyloidogenicity of \u03b2A4 and \u03b2A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J Biol Chem. 1992;267:18210\u20137.","journal-title":"J Biol Chem"},{"key":"133_CR26","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci. 2000;3:1301\u20136.","journal-title":"Nat Neurosci"},{"key":"133_CR27","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1523\/JNEUROSCI.21-20-08053.2001","volume":"21","author":"E Paxinou","year":"2001","unstructured":"Paxinou E, Chen Q, Weisse M, Giasson BI, Norris EH, Rueter SM, et al. Induction of \u03b1-synuclein aggregation by intracellular nitrative insult. J Neurosci. 2001;21:8053\u201361.","journal-title":"J Neurosci"},{"key":"133_CR28","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1096\/fj.04-3437fje","volume":"19","author":"R Cappai","year":"2005","unstructured":"Cappai R, Leck S-L, Tew DJ, Williamson NA, Smith DP, Galatis D, et al. Dopamine promotes \u03b1-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. FASEB J. 2005;19:1377\u20139.","journal-title":"FASEB J"},{"key":"133_CR29","doi-asserted-by":"crossref","first-page":"e13250","DOI":"10.1371\/journal.pone.0013250","volume":"5","author":"L Liu-Yesucevitz","year":"2010","unstructured":"Liu-Yesucevitz L, Bilgutay A, Zhang Y-J, Vanderwyde T, Citro A, Mehta T, et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of culture cells and pathological brain tissue. PLoS ONE. 2010;5:e13250.","journal-title":"PLoS ONE"},{"key":"133_CR30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1523\/JNEUROSCI.22-02-00446.2002","volume":"22","author":"K Uryu","year":"2002","unstructured":"Uryu K, Laurer H, McIntosh T, Pratic\u00f2 D, Martinez D, Leight S, et al. Repetitive mild brain trauma accelerates A\u03b2 deposition, lipid peroxication, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. J Neurosci. 2002;22:446\u201354.","journal-title":"J Neurosci"},{"key":"133_CR31","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1089\/neu.2005.22.1134","volume":"22","author":"Y Yoshiyama","year":"2005","unstructured":"Yoshiyama Y, Uryu K, Higuchi M, Longhi L, Hoover R, Fujimoto S, et al. Enhanced neurofibrillary tangle formation, cerebral atrophy, and cognitive deficits induced by repeititve mild brain injury in a transgenic tauopathy mouse model. J Neurotrauma. 2005;22:1134\u201341.","journal-title":"J Neurotrauma"},{"key":"133_CR32","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrm3810","volume":"15","author":"TPJ Knowles","year":"2014","unstructured":"Knowles TPJ, Vendruscolo M, Dobson CM. The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol. 2014;15:384\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"133_CR33","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1073\/pnas.1418155112","volume":"112","author":"ZA Levine","year":"2015","unstructured":"Levine ZA, Larini L, LaPointe NE, Feinstein SC, Shea J-E. Regulation and aggregation of intrinsically disordered peptides. Proc Natl Acad Sci USA. 2015;112:2758\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"133_CR34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.biopsych.2018.01.007","volume":"83","author":"R Srivastava","year":"2018","unstructured":"Srivastava R, Faust T, Ramos A, Ishizuka K, Sawa A. Dynamic changes of the mitochondria in psychiatric illnesses: new mechanistic insights from human neuronal models. Biol Psychiatry. 2018;83:751\u201360.","journal-title":"Biol Psychiatry"},{"key":"133_CR35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","volume":"114","author":"NJ Cairns","year":"2007","unstructured":"Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007;114:5\u201322.","journal-title":"Acta Neuropathol"},{"key":"133_CR36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.24198","volume":"76","author":"FP Diekstra","year":"2014","unstructured":"Diekstra FP, Van Deerlin VM, van Swieten JC, Al-Chalabi A, Ludolph AC, Weishaupt JH, et al. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis. Ann Neurol. 2014;76:120\u201333.","journal-title":"Ann Neurol"},{"key":"133_CR37","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4088\/JCP.10m06382oli","volume":"72","author":"JD Woolley","year":"2011","unstructured":"Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011;72:126\u201333.","journal-title":"J Clin Psychiatry"},{"issue":"Pt 8","key":"133_CR38","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease. Brain. 1999;122(Pt 8):1437\u201348.","journal-title":"Brain"},{"key":"133_CR39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archneur.58.2.273","volume":"58","author":"SC Kirkwood","year":"2001","unstructured":"Kirkwood SC, Su JL, Conneally PM, Foroud T. Progression of symptoms in the early and middle stages of Huntington disease. Arch Neurol. 2001;58:273\u20138.","journal-title":"Arch Neurol"},{"key":"133_CR40","first-page":"317","volume":"26","author":"G Huntington","year":"1872","unstructured":"Huntington G. On chorea. Med Surg Rep. 1872;26:317\u201321.","journal-title":"Med Surg Rep"},{"key":"133_CR41","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.biopsych.2013.08.020","volume":"75","author":"PS Murray","year":"2014","unstructured":"Murray PS, Kumar S, Demichele-Sweet MA, Sweet RA. Psychosis in Alzheimer\u2019s disease. Biol Psychiatry. 2014;75:542\u201352.","journal-title":"Biol Psychiatry"},{"key":"133_CR42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.biopsych.2013.11.006","volume":"75","author":"PS Pressman","year":"2014","unstructured":"Pressman PS, Miller BL. Diagnosis and management of behavioral variant frontotemporal dementia. Biol Psychiatry. 2014;75:574\u201381.","journal-title":"Biol Psychiatry"},{"key":"133_CR43","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.biopsych.2015.03.028","volume":"78","author":"D Galimberti","year":"2015","unstructured":"Galimberti D, Dell\u2019Osso B, Altamura AC, Scarpini E. Psychiatric symptoms in frontotemporal dementia: epidemiology, phenotypes, and differential diagnosis. Biol Psychiatry. 2015;78:684\u201392.","journal-title":"Biol Psychiatry"},{"key":"133_CR44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/09540261.2013.765389","volume":"25","author":"M Harciarek","year":"2013","unstructured":"Harciarek M, Malaspina D, Sun T, Goldberg E. Schizophrenia and frontotemporal dementia: shared causation? Int Rev Psychiatry. 2013;25:168\u201377.","journal-title":"Int Rev Psychiatry"},{"key":"133_CR45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0166-2236(88)90060-4","volume":"11","author":"DR Weinberger","year":"1988","unstructured":"Weinberger DR. Schizophrenia and the frontal lobe. Trends Neurosci. 1988;11:367\u201370.","journal-title":"Trends Neurosci"},{"key":"133_CR46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fnagi.2016.00010","volume":"8","author":"R Zanardini","year":"2016","unstructured":"Zanardini R, Ciani M, Benussi L, Ghidoni R. Molecular pathways bridging frontotemporal lobar degeneration and psychiatric disorders. Front Aging Neurosci. 2016;8:10.","journal-title":"Front Aging Neurosci"},{"key":"133_CR47","doi-asserted-by":"crossref","first-page":"901082","DOI":"10.1155\/2013\/901082","volume":"2013","author":"M Ventriglia","year":"2013","unstructured":"Ventriglia M, Zanardini R, Bonomini C, Zanetti O, Volpe D, Pasqualetti P, et al. Serum brain-derived neurotrophic factor levels in different neurological diseases. Biomed Res Int. 2013;2013:901082.","journal-title":"Biomed Res Int"},{"key":"133_CR48","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/JAD-2012-120226","volume":"31","author":"B Borroni","year":"2012","unstructured":"Borroni B, Bianchi M, Premi E, Alberici A, Archetti S, Paghera B, et al. The brain-derived neurotrophic factor Val66Met polymorphism is associated with reduced hippocampus perfusion in frontotemporal lobar degeneration. J Alzheimer\u2019s Dis. 2012;31:243\u201351.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"133_CR49","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neubiorev.2016.05.031","volume":"68","author":"M Li","year":"2016","unstructured":"Li M, Chan H, Xiao X. BDNF Val66Met polymorphism and bipolar disorder in European populations: a risk association in case-control, family-based and GWAS studies. Neurosci Biobehav Rev. 2016;68:218\u201333.","journal-title":"Neurosci Biobehav Rev"},{"key":"133_CR50","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-016-0707-9","volume":"16","author":"DA Olszewska","year":"2016","unstructured":"Olszewska DA, Lonergan R, Fallon EM, Lynch T. Genetics of frontotemporal dementia. Curr Neurol Neurosci Rep. 2016;16:107.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"133_CR51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1192\/bjp.bp.109.068981","volume":"197","author":"D Schoder","year":"2010","unstructured":"Schoder D, Hannequin D, Martinaud O, Opolczynski G, Guyant-Mar\u00e9chal L, Le Ber I, et al. Morbid risk for schizophrenia in first-degree relatives of people with frontotemporal dementia. Br J Psychiatry. 2010;197:28\u201335.","journal-title":"Br J Psychiatry"},{"key":"133_CR52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jns.2009.07.011","volume":"287","author":"M Carecchio","year":"2009","unstructured":"Carecchio M, Fenoglio C, De Riz M, Guidi I, Comi C, Cortini F, et al. Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic mild cognitive impairment converted to Alzheimer\u2019s disease. J Neurol Sci. 2009;287:291\u20133.","journal-title":"J Neurol Sci"},{"key":"133_CR53","doi-asserted-by":"crossref","first-page":"e32164","DOI":"10.1371\/journal.pone.0032164","volume":"7","author":"D Galimberti","year":"2012","unstructured":"Galimberti D, Dell\u2019Osso B, Fenoglio C, Villa C, Cortini F, Serpente M, et al. Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia. PLoS ONE. 2012;7:e32164.","journal-title":"PLoS ONE"},{"key":"133_CR54","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368:107\u201316.","journal-title":"N Engl J Med"},{"key":"133_CR55","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2016.247","volume":"22","author":"K Collste","year":"2017","unstructured":"Collste K, Plaven-Sigray P, Fatouros-Bergman H, Victorsson P, Schain M, Forsberg A, et al. Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [(11)C]PBR28. Mol Psychiatry. 2017;22:850\u20136.","journal-title":"Mol Psychiatry"},{"key":"133_CR56","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S2215-0366(18)30048-8","volume":"5","author":"E Setiawan","year":"2018","unstructured":"Setiawan E, Attwells S, Wilson AA, Mizrahi R, Rusjan PM, Miler L, et al. Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study. Lancet Psychiatry. 2018;5:339\u201347.","journal-title":"Lancet Psychiatry"},{"key":"133_CR57","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130\u20133.","journal-title":"Science"},{"key":"133_CR58","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/00048670903001984","volume":"43","author":"D Velakoulis","year":"2009","unstructured":"Velakoulis D, Walterfang M, Mocellin R, Pantelis C, Dean B, McLean C. Abnormal hippocampal distribution of TDP-43 in patients with-late onset psychosis. Aus N Z J Psychiatry. 2009;43:739\u201345.","journal-title":"Aus N Z J Psychiatry"},{"key":"133_CR59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.schres.2008.08.033","volume":"108","author":"FJ Mateen","year":"2009","unstructured":"Mateen FJ, Josephs KA. TDP-43 is not present in brain tissue of patients with schizophrenia. Schizophr Res. 2009;108:297\u20138.","journal-title":"Schizophr Res"},{"key":"133_CR60","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archneurol.2010.254","volume":"67","author":"F Geser","year":"2010","unstructured":"Geser F, Robinson JL, Malunda JA, Xie SX, Clark CM, Kwong LK, et al. Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Arch Neurol. 2010;67:1238\u201350.","journal-title":"Arch Neurol"},{"issue":"7","key":"133_CR61","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.biopsych.2018.03.008","volume":"84","author":"Ryo Endo","year":"2018","unstructured":"Endo R, Takashima N, Nekooki-Machida Y, Komi Y, Hui KK-W, Takao M, et al. TDP-43 and DISC1 co-aggregation disrupts dendritic local translation and mental function in FTLD. Biol Psychiatry. 2018; https:\/\/doi.org\/10.1016\/j.biopsych.2018.03.008 .","journal-title":"Biological Psychiatry"},{"key":"133_CR62","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1172\/JCI85594","volume":"127","author":"M Tanaka","year":"2017","unstructured":"Tanaka M, Ishizuka K, Nekooki-Machida Y, Endo R, Takashima N, Sasaki H, et al. Aggregation of scaffolding protein DISC1 dysregulates phosphodiesterase 4 in Huntington\u2019s disease. J Clin Invest. 2017;127:1438\u201350.","journal-title":"J Clin Invest"},{"key":"133_CR63","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1017\/S0033291700017608","volume":"20","author":"CJ Bruton","year":"1990","unstructured":"Bruton CJ, Crow TJ, Frith CD, Johnstone EC, Owens DGC, Roberts GW. Schizophrenia and the brain: a prospective clinico-neuropathological study. Psychol Med. 1990;20:285\u2013304.","journal-title":"Psychol Med"},{"key":"133_CR64","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1176\/appi.ajp.160.5.867","volume":"160","author":"D Religa","year":"2003","unstructured":"Religa D, Laudon H, Styczynska M, Winblad B, N\u00e4slud J, Haroutunian V. Amyloid \u03b2 pathology in Alzheimer\u2019s disease and schizophrenia. Am J Psychiatry. 2003;160:867\u201372.","journal-title":"Am J Psychiatry"},{"key":"133_CR65","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00401-009-0492-5","volume":"117","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA. Lewy body\/\u03b1-synucleinopathy in schizophrenia and depression: a preliminary neuropathological study. Acta Neuropathol. 2009;117:423\u20137.","journal-title":"Acta Neuropathol"},{"key":"133_CR66","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.49","volume":"7","author":"J Gibson","year":"2017","unstructured":"Gibson J, Russ TC, Adams MJ, Clarke TK, Howard DM, Hall LS, et al. Assessing the presence of shared genetic architecture between Alzheimer\u2019s disease and major depressive disorder using genome-wide association data. Transl Psychiatry. 2017;7:e1094.","journal-title":"Transl Psychiatry"},{"key":"133_CR67","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1523\/JNEUROSCI.5389-07.2008","volume":"28","author":"SR Leliveld","year":"2008","unstructured":"Leliveld SR, Bader V, Hendriks P, Prikulis I, Sajnani G, Requena JR, et al. Insolubility of Disrupted-in-Schizophrenia 1 disrupts oligomer-dependent interactions with nuclear distribution element 1 and is associated with sporadic mental disease. J Neurosci. 2008;28:3839\u201345.","journal-title":"J Neurosci"},{"key":"133_CR68","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.biopsych.2011.03.027","volume":"70","author":"P Ottis","year":"2011","unstructured":"Ottis P, Bader V, Trossbach SV, Kretzschmar H, Michel M, Leliveld SR, et al. Convergence of two independent mental disease genes on the protein level: recruitment of dysbindin to cell-invasive Disrupted-in-Schizophrenia 1 aggresomes. Biol Psychiatry. 2011;70:604\u201310.","journal-title":"Biol Psychiatry"},{"key":"133_CR69","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000447358","volume":"2","author":"LG Nucifora","year":"2016","unstructured":"Nucifora LG, Wu YC, Lee BJ, Sha L, Margolis RL, Ross CA, et al. A mutation in NPAS3 that segregates with schizophrenia in a small family leads to protein aggregation. Mol Neuropsychiatry. 2016;2:133\u201344.","journal-title":"Mol Neuropsychiatry"},{"key":"133_CR70","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1093\/hmg\/dds273","volume":"21","author":"V Bader","year":"2012","unstructured":"Bader V, Tomppo L, Trossbach SV, Bradshaw NJ, Prikulis I, Leliveld SR, et al. Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits. Hum Mol Genet. 2012;21:4406\u201318.","journal-title":"Hum Mol Genet"},{"key":"133_CR71","doi-asserted-by":"crossref","first-page":"e111196","DOI":"10.1371\/journal.pone.0111196","volume":"9","author":"NJ Bradshaw","year":"2014","unstructured":"Bradshaw NJ, Bader V, Prikulis I, Lueking A, M\u00fcllner S, Korth C. Aggregation of the protein TRIOBP-1 and its potential relevance to schizophrenia. PLoS ONE. 2014;9:e111196.","journal-title":"PLoS ONE"},{"key":"133_CR72","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrn3120","volume":"12","author":"NJ Brandon","year":"2011","unstructured":"Brandon NJ, Sawa A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci. 2011;12:707\u201322.","journal-title":"Nat Rev Neurosci"},{"key":"133_CR73","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1515\/hsz-2013-0178","volume":"394","author":"ASK Yerabham","year":"2013","unstructured":"Yerabham ASK, Weiergr\u00e4ber OH, Bradshaw NJ, Korth C. Revisiting Disrupted in Schizophrenia 1 as a scaffold protein. Biol Chem. 2013;394:1425\u201337.","journal-title":"Biol Chem"},{"key":"133_CR74","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/hmg\/9.9.1415","volume":"9","author":"JK Millar","year":"2000","unstructured":"Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CAM, et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet. 2000;9:1415\u201325.","journal-title":"Hum Mol Genet"},{"key":"133_CR75","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sj.mp.4002106","volume":"13","author":"JE Chubb","year":"2008","unstructured":"Chubb JE, Bradshaw NJ, Soares DC, Porteous DJ, Millar JK. The DISC locus in psychiatric illness. Mol Psychiatry. 2008;13:36\u201364.","journal-title":"Mol Psychiatry"},{"key":"133_CR76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11515-012-1254-7","volume":"8","author":"PA Thomson","year":"2013","unstructured":"Thomson PA, Malavasi ELV, Gr\u00fcnewald E, Soares DC, Borkowska M, Millar JK. DISC1 genetics, biology and psychiatric illness. Front Biol. 2013;8:1\u201331.","journal-title":"Front Biol"},{"key":"133_CR77","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/mp.2012.182","volume":"18","author":"PF Sullivan","year":"2013","unstructured":"Sullivan PF. Questions about DISC1 as a genetic risk factor for schizophrenia. Mol Psychiatry. 2013;18:1050\u20132.","journal-title":"Mol Psychiatry"},{"key":"133_CR78","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/mp.2013.160","volume":"19","author":"DJ Porteous","year":"2014","unstructured":"Porteous DJ, Thomson PA, Millar JK, Evans KL, Hennah W, Soares DC, et al. DISC1 as a genetic risk factor for schizophrenia and related major mental illness: response to Sullivan. Mol Psychiatry. 2014;19:141\u20133.","journal-title":"Mol Psychiatry"},{"key":"133_CR79","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/mp.2015.16","volume":"20","author":"MS Farrell","year":"2015","unstructured":"Farrell MS, Werge T, Sklar P, Owen MJ, Ophoff RA, O\u2019Donovan MC, et al. Evaluating historical candidate genes for schizophrenia. Mol Psychiatry. 2015;20:555\u201362.","journal-title":"Mol Psychiatry"},{"key":"133_CR80","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/mp.2016.154","volume":"21","author":"M Niwa","year":"2016","unstructured":"Niwa M, Cash-Padgett T, Kubo KI, Saito A, Ishii K, Sumitomo A, et al. DISC1 a key molecular lead in psychiatry and neurodevelopment: No-More Disrupted-in-Schizophrenia 1. Mol Psychiatry. 2016;21:1488\u20139.","journal-title":"Mol Psychiatry"},{"key":"133_CR81","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature09859","volume":"473","author":"K Ishizuka","year":"2011","unstructured":"Ishizuka K, Kamiya A, Oh EC, Kanki H, Seshadri S, Robinson JF, et al. DISC1-dependent switch from progenitor proliferation to migration in the developing cortex. Nature. 2011;473:92\u20136.","journal-title":"Nature"},{"key":"133_CR82","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/mp.2015.194","volume":"21","author":"SV Trossbach","year":"2016","unstructured":"Trossbach SV, Bader V, Hecher L, Pum ME, Masoud ST, Prikulis I, et al. Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits. Mol Psychiatry. 2016;21:1561\u201372.","journal-title":"Mol Psychiatry"},{"key":"133_CR83","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/hmg\/dds018","volume":"21","author":"TA Atkin","year":"2012","unstructured":"Atkin TA, Brandon NJ, Kittler JT. Disrupted in Schizophrenia 1 forms pathological aggresomes that disrupt its function in intracellular transport. Hum Mol Genet. 2012;21:2017\u201328.","journal-title":"Hum Mol Genet"},{"key":"133_CR84","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nlm.2017.10.015","volume":"146","author":"An-Li Wang","year":"2017","unstructured":"Wang A-L, Fazari B, Chao OY, Nikolaus S, Trossbach SV, Korth C, et al. Intra-nasal dopamine alleviates cognitive deficits in tgDISC1 rats which over-express the human DISC1 gene. Neurobiol Learn Memory. 2017; https:\/\/doi.org\/10.1016\/j.nlm.2017.10.015 .","journal-title":"Neurobiology of Learning and Memory"},{"key":"133_CR85","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.euroneuro.2013.06.005","volume":"23","author":"P Seeman","year":"2013","unstructured":"Seeman P. Schizophrenia and dopamine receptors. Eur Neuropsychopharmacol. 2013;23:999\u20131009.","journal-title":"Eur Neuropsychopharmacol"},{"key":"133_CR86","doi-asserted-by":"crossref","DOI":"10.1038\/srep34946","volume":"6","author":"H Hamburg","year":"2016","unstructured":"Hamburg H, Trossbach SV, Bader V, Chwiesko C, Kipar A, Sauvage M, et al. Simultaneous effects on parvalbumin-positive interneuron and dopaminergic system development in a transgenic rat model for sporadic schizophrenia. Sci Rep. 2016;6:34946.","journal-title":"Sci Rep"},{"key":"133_CR87","doi-asserted-by":"crossref","first-page":"160328","DOI":"10.1098\/rsob.160328","volume":"7","author":"S Zhu","year":"2017","unstructured":"Zhu S, Abounit S, Korth C, Zurzolo C. Transfer of Disrupted-in-Schizophrenia 1 aggregates between neuronal-like cells occurs in tunnelling nanotubes and is promoted by dopamine. Open Biol. 2017;7:160328.","journal-title":"Open Biol"},{"key":"133_CR88","doi-asserted-by":"crossref","unstructured":"Bader V, Ottis P, Pum M, Huston JP, Korth C. Generation, purification, and characterization of cell-invasive DISC1 protein species. J Vis Exp. 2012;e4132.","DOI":"10.3791\/4132"},{"key":"133_CR89","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.mp.4002125","volume":"13","author":"X Zhou","year":"2008","unstructured":"Zhou X, Geyer MA, Kelsoe JR. Does Disrupted-in-Schizophrenia (DISC1) generate fusion transcripts? Mol Psychiatry. 2008;13:361\u20133.","journal-title":"Mol Psychiatry"},{"key":"133_CR90","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/mp.2009.127","volume":"15","author":"X Zhou","year":"2010","unstructured":"Zhou X, Chen Q, Schaukowitch K, Kelsoe JR, Geyer MA. Insoluble DISC1\u2013Boymaw fusion proteins generated by DISC1 translocation. Mol Psychiatry. 2010;15:670\u20135.","journal-title":"Mol Psychiatry"},{"key":"133_CR91","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1093\/hmg\/dds169","volume":"21","author":"JE Eykelenboom","year":"2012","unstructured":"Eykelenboom JE, Briggs GJ, Bradshaw NJ, Soares DC, Ogawa F, Christie S, et al. A t(1;11) translocation linked to schizophrenia and affective disorders gives rise to aberrant chimeric DISC1 transcripts that encode structurally altered, deleterious mitochondrial proteins. Hum Mol Genet. 2012;21:3374\u201386.","journal-title":"Hum Mol Genet"},{"key":"133_CR92","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/sj.mp.4001667","volume":"10","author":"NA Sachs","year":"2005","unstructured":"Sachs NA, Sawa A, Holmes SE, Ross CA, DeLisi LE, Margolis RL. A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder. Mol Psychiatry. 2005;10:758\u201364.","journal-title":"Mol Psychiatry"},{"key":"133_CR93","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nature13716","volume":"515","author":"Z Wen","year":"2014","unstructured":"Wen Z, Nguyen HN, Guo Z, Lalli MA, Wang X, Su Y, et al. Synaptic dysregulation in a human iPS cell model of mental disorders. Nature. 2014;515:414\u20138.","journal-title":"Nature"},{"key":"133_CR94","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1074\/jbc.M116.773903","volume":"292","author":"ASK Yerabham","year":"2017","unstructured":"Yerabham ASK, Mas PJ, Decker C, Soares DC, Weiergr\u00e4ber OH, Nagel-Steger L, et al. A structural organization for Disrupted in Schizophrenia 1, identified by high-throughput screening, reveals distinctly folded regions which are bisected by mental illness-related mutations. J Biol Chem. 2017;292:6468\u201377.","journal-title":"J Biol Chem"},{"key":"133_CR95","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/mp.2014.100","volume":"20","author":"N Shahani","year":"2015","unstructured":"Shahani N, Seshadri S, Jaaro-Peled H, Ishizuka K, Hirota-Tsuyada Y, Wang Q, et al. DISC1 regulates trafficking and processing of APP and A\u03b2 generation. Mol Psychiatry. 2015;20:874\u20139.","journal-title":"Mol Psychiatry"},{"key":"133_CR96","first-page":"440","volume":"41","author":"QS Deng","year":"2016","unstructured":"Deng Q-S, Dong X-Y, Wu H, Wang W, Wang Z-T, Zhu J-W, et al. Disrupted-in-Schizophrenia-1 attenuates amyloid-\u03b2 generation and cognitive deficits in APP\/PS1 transgenic mice by reduction of \u03b2-site APP-cleaving enzyme 1 levels. Neuropharmacology. 2016;41:440\u201363.","journal-title":"Neuropharmacology"},{"key":"133_CR97","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/341750","volume":"71","author":"RE Straub","year":"2002","unstructured":"Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet. 2002;71:337\u201348.","journal-title":"Am J Hum Genet"},{"key":"133_CR98","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ng1229","volume":"35","author":"W Li","year":"2003","unstructured":"Li W, Zhang Q, Oiso N, Novak EK, Gautam R, O\u2019Brien EP, et al. Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat Genet. 2003;35:84\u20139.","journal-title":"Nat Genet"},{"key":"133_CR99","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1074\/jbc.M900141200","volume":"284","author":"HS Hoe","year":"2009","unstructured":"Hoe H-S, Fu Z, Makarova A, Lee J-Y, Lu C, Feng L, et al. The effects of amyloid precursor protein on postsynaptic composition and activity. J Biol Chem. 2009;284:8495\u2013506.","journal-title":"J Biol Chem"},{"key":"133_CR100","doi-asserted-by":"crossref","first-page":"19593","DOI":"10.1073\/pnas.0904289106","volume":"106","author":"Y Ji","year":"2009","unstructured":"Ji Y, Yang F, Papaleo F, Wang H-X, Gao W-J, Weinberger DR, et al. Role of dysbindin in dopamine receptor trafficking and cortical GABA function. Proc Natl Acad Sci USA. 2009;106:19593\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"133_CR101","doi-asserted-by":"crossref","first-page":"15032","DOI":"10.1038\/celldisc.2015.32","volume":"1","author":"Y Xu","year":"2015","unstructured":"Xu Y, Sun Y, Ye H, Zhu L, Liu J, Wu X, et al. Increased dysbindin-1B isoform expression in schizophrenia and its propensity in aggresome formation. Cell Discov. 2015;1:15032.","journal-title":"Cell Discov"},{"key":"133_CR102","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuroscience.2015.02.016","volume":"291","author":"CY Zhu","year":"2015","unstructured":"Zhu C-Y, Shen Y, Xu Q. Propagation of dysbindin-1B aggregates: exosome-mediated transmission of neurotoxic deposits. Neuroscience. 2015;291:301\u201316.","journal-title":"Neuroscience"},{"key":"133_CR103","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuroscience.2016.07.008","volume":"333","author":"W Yang","year":"2016","unstructured":"Yang W, Zhu C, Shen Y, Xu Q. The pathogenic mechanism of dysbindin-1B toxic aggregation: BLOC-1 and intercellular vesicle trafficking. Neuroscience. 2016;333:78\u201391.","journal-title":"Neuroscience"},{"key":"133_CR104","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12035-012-8242-4","volume":"45","author":"N Yamashita","year":"2012","unstructured":"Yamashita N, Goshima Y. Collapsin response mediator proteins regulate neuronal development and plasticity by switching their phosphorylation status. Mol Neurobiol. 2012;45:234\u201346.","journal-title":"Mol Neurobiol"},{"key":"133_CR105","volume":"5","author":"F Nakamura","year":"2014","unstructured":"Nakamura F, Kumeta K, Hida T, Isono T, Nakayama Y, Kuramata-Matsuoka E, et al. Amino- and carboxyl-terminal domains of filamin-A interact with CRMP1 to mediate Sema3A signalling. Nat Commun. 2014;5:5325.","journal-title":"Nat Commun"},{"key":"133_CR106","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/sj.mp.4000696","volume":"5","author":"NL Johnston-Wilson","year":"2000","unstructured":"Johnston-Wilson NL, Sims CD, Hofmann J-P, Anderson L, Shore AD, Torrey EF, et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. Mol Psychiatry. 2000;5:142\u20139.","journal-title":"Mol Psychiatry"},{"key":"133_CR107","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1002\/pmic.200500069","volume":"6","author":"CL Beasley","year":"2006","unstructured":"Beasley CL, Pennington K, Behan A, Wait R, Dunn MJ, Cotter D. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics. 2006;6:3414\u201325.","journal-title":"Proteomics"},{"key":"133_CR108","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1101\/gr.182444.114","volume":"25","author":"M Stroedicke","year":"2015","unstructured":"Stroedicke M, Bounab Y, Strempel N, Klockmeier K, Yigit S, Friedrich RP, et al. Systematic interaction network filtering identifies CRMP1 as a novel suppressor of huntingtin misfolding and neurotoxicity. Genome Res. 2015;25:701\u201313.","journal-title":"Genome Res"},{"issue":"Pt 2","key":"133_CR109","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1242\/jcs.114.2.389","volume":"114","author":"K Seipel","year":"2001","unstructured":"Seipel K, O\u2019Brien SP, Iannotti E, Medley QG, Streuli M. Tara, a novel F-actin binding protein, associates with the Trio guanine nucleotide exchange factor and regulates actin cytoskeletal organization. J Cell Sci. 2001;114(Pt 2):389\u201399.","journal-title":"J Cell Sci"},{"key":"133_CR110","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.1074\/jbc.M116.767939","volume":"292","author":"NJ Bradshaw","year":"2017","unstructured":"Bradshaw NJ, Yerabham ASK, Marreiros R, Zhang T, Nagel-Steger L, Korth C. An unpredicted aggregation-critical region of the actin-polymerizing protein TRIOBP-1\/Tara, determined by elucidation of its domain structure. J Biol Chem. 2017;292:9583\u201398.","journal-title":"J Biol Chem"},{"key":"133_CR111","volume":"6","author":"JH Hong","year":"2016","unstructured":"Hong J-H, Kwak Y, Woo Y, Park C, Lee S-A, Lee H, et al. Regulation of the actin cytoskeleton by the Ndel1-Tara complex is critical for cell migration. Sci Rep. 2016;6:31827.","journal-title":"Sci Rep"},{"key":"133_CR112","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.yexcr.2012.07.001","volume":"318","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Wang C, Lan J, Yu J, Jin C, Huang H. Phosphorylation of Tara by Plk1 is essential for faithful chromosome segregation in mitosis. Exp Cell Res. 2012;318:2344\u201352.","journal-title":"Exp Cell Res"},{"key":"133_CR113","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/mp.2009.18","volume":"14","author":"PR Maycox","year":"2009","unstructured":"Maycox PR, Kelly F, Taylor A, Bates S, Reid J, Logendra R, et al. Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry. 2009;14:1083\u201394.","journal-title":"Mol Psychiatry"},{"key":"133_CR114","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bbrc.2008.01.022","volume":"367","author":"J Yu","year":"2008","unstructured":"Yu J, Lan J, Zhu Y, Li X, Lai X, Xue Y, et al. The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of Tara. Biochem Biophys Res Commun. 2008;367:805\u201312.","journal-title":"Biochem Biophys Res Commun"},{"key":"133_CR115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0925-4773(99)00182-3","volume":"88","author":"EW Brunskill","year":"1999","unstructured":"Brunskill EW, Witte DP, Shreiner AB, Potter SS. Characterization of Npas3, a novel basic helix-loop-helix PAS gene expressed in the developing mouse nervous system. Mech Dev. 1999;88:237\u201341.","journal-title":"Mech Dev"},{"key":"133_CR116","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/jmg.40.5.325","volume":"40","author":"D Kamnasaran","year":"2003","unstructured":"Kamnasaran D, Muir WJ, Ferguson-Smith MA, Cox DW. Disruption of the neuronal PAS3 gene in a family affected with schizophrenia. J Med Genet. 2003;40:325\u201332.","journal-title":"J Med Genet"},{"key":"133_CR117","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ajmg.b.30204","volume":"136B","author":"BS Pickard","year":"2005","unstructured":"Pickard BS, Malloy MP, Porteous DJ, Blackwood DHR, Muir WJ. Disruption of a brain transcription factor, NPAS3, is associated with schizophrenia and learning disability. Am J Med Genet B Neuropsychiatr Genet. 2005;136B:26\u201332.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"133_CR118","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/mp.2012.192","volume":"19","author":"L Yu","year":"2014","unstructured":"Yu L, Arbez N, Nucifora LG, Sell GL, DeLisi LE, Ross CA, et al. A mutation in NPAS3 segregates with mental illness in a small family. Mol Psychiatry. 2014;19:7\u20138.","journal-title":"Mol Psychiatry"},{"key":"133_CR119","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.mcn.2004.11.003","volume":"28","author":"NJ Brandon","year":"2005","unstructured":"Brandon NJ, Schurov I, Camargo LM, Handford EJ, Duran-Jimeriz B, Hunt P, et al. Subcellular targetting of DISC1 is dependant on a domain independent from the Nudel binding site. Mol Cell Neurosci. 2005;28:613\u201324.","journal-title":"Mol Cell Neurosci"},{"key":"133_CR120","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1021\/bi900901e","volume":"48","author":"SR Leliveld","year":"2009","unstructured":"Leliveld SR, Hendriks P, Michel M, Sajnani G, Bader V, Trossbach S, et al. Oligomer assembly of the C-terminal DISC1 domain (640-854) is controlled by self-association motifs and disease-associated polymorphism S704C. Biochemistry. 2009;48:7746\u201355.","journal-title":"Biochemistry"},{"key":"133_CR121","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jmb.2004.02.002","volume":"337","author":"JJ Ward","year":"2004","unstructured":"Ward JJ, Sodhi JS, McGuffin LJ, Buxton BF, Jones DT. Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J Mol Biol. 2004;337:635\u201345.","journal-title":"J Mol Biol"},{"key":"133_CR122","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","volume":"35","author":"OD Howes","year":"2009","unstructured":"Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull. 2009;35:549\u201362.","journal-title":"Schizophr Bull"},{"key":"133_CR123","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1007\/s00429-018-1660-y","volume":"223","author":"E Gonzalez de San Roman","year":"2018","unstructured":"Gonzalez de San Roman E, Bidmon HJ, Malisic M, Susnea I, Kuppers A, Hubbers R, et al. Molecular composition of the human primary visual cortex profiled by multimodal mass spectrometry imaging. Brain Struct Funct. 2018;223:2767\u201383.","journal-title":"Brain Struct Funct"},{"key":"133_CR124","doi-asserted-by":"crossref","unstructured":"Zhang S, Smailagic N, Hyde C, Noel-Storr AH, Takwoingi Y, McShane R, et al. (11)C-PIB-PET for the early diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2014;CD010386.","DOI":"10.1002\/14651858.CD010386.pub2"},{"key":"133_CR125","first-page":"73","volume":"8","author":"A Badhwar","year":"2017","unstructured":"Badhwar A, Tam A, Dansereau C, Orban P, Hoffstaedter F, Bellec P. Resting-state network dysfunction in Alzheimer\u2019s disease: a systematic review and meta-analysis. Alzheimers Dement. 2017;8:73\u201385.","journal-title":"Alzheimers Dement"},{"key":"133_CR126","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/brain\/awx353","volume":"141","author":"MC Hoenig","year":"2018","unstructured":"Hoenig MC, Bischof GN, Seemiller J, Hammes J, Kukolja J, Onur OA, et al. Networks of tau distribution in Alzheimer\u2019s disease. Brain. 2018;141:568\u201381.","journal-title":"Brain"},{"key":"133_CR127","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jalz.2016.06.2361","volume":"13","author":"SS Mirza","year":"2017","unstructured":"Mirza SS, Ikram MA, Bos D, Mihaescu R, Hofman A, Tiemeier H. Mild cognitive impairment and risk of depression and anxiety: a population-based study. Alzheimers Dement. 2017;13:130\u20139.","journal-title":"Alzheimers Dement"},{"key":"133_CR128","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jamapsychiatry.2016.3162","volume":"74","author":"Z Ismail","year":"2017","unstructured":"Ismail Z, Elbayoumi H, Fischer CE, Hogan DB, Millikin CP, Schweizer T, et al. Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74:58\u201367.","journal-title":"JAMA Psychiatry"},{"key":"133_CR129","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","volume":"63","author":"RL Ownby","year":"2006","unstructured":"Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006;63:530\u20138.","journal-title":"Arch Gen Psychiatry"},{"key":"133_CR130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-003-1761-y","volume":"174","author":"PJ Harrison","year":"2004","unstructured":"Harrison PJ. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology. 2004;174:151\u201362.","journal-title":"Psychopharmacology"},{"key":"133_CR131","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/sj.npp.1300554","volume":"29","author":"RA Sweet","year":"2004","unstructured":"Sweet RA, Hamilton RL, Butters MA, Mulsant BH, Pollock BG, Lewis DA, et al. Neuropathologic correlates of late-onset major depression. Neuropsychopharmacology. 2004;29:2242\u201350.","journal-title":"Neuropsychopharmacology"},{"key":"133_CR132","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpsychores.2016.12.011","volume":"93","author":"A Gabilondo","year":"2017","unstructured":"Gabilondo A, Alonso-Moran E, Nuno-Solinis R, Orueta JF, Iruin A. Comorbidities with chronic physical conditions and gender profiles of illness in schizophrenia. Results from PREST, a new health dataset. J Psychosom Res. 2017;93:102\u20139.","journal-title":"J Psychosom Res"},{"key":"133_CR133","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/hmg\/ddt465","volume":"23","author":"MA Nalls","year":"2014","unstructured":"Nalls MA, Saad M, Noyce AJ, Keller MF, Schrag A, Bestwick JP, et al. Genetic comorbidities in Parkinson\u2019s disease. Hum Mol Genet. 2014;23:831\u201341.","journal-title":"Hum Mol Genet"},{"key":"133_CR134","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/WNL.58.10.1501","volume":"58","author":"AG Schuurman","year":"2002","unstructured":"Schuurman AG, van den Akker M, Ensinck KT, Metsemakers JF, Knottnerus JA, Leentjens AF, et al. Increased risk of Parkinson\u2019s disease after depression: a retrospective cohort study. Neurology. 2002;58:1501\u20134.","journal-title":"Neurology"},{"key":"133_CR135","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.23969","volume":"74","author":"S Byrne","year":"2013","unstructured":"Byrne S, Heverin M, Elamin M, Bede P, Lynch C, Kenna K, et al. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis. Ann Neurol. 2013;74:699\u2013708.","journal-title":"Ann Neurol"},{"key":"133_CR136","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14774","volume":"8","author":"RL McLaughlin","year":"2017","unstructured":"McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O\u2019Brien M, Kahn RS, et al. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nat Commun. 2017;8:14774.","journal-title":"Nat Commun"},{"key":"133_CR137","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/jamaneurol.2017.2699","volume":"74","author":"M O\u2019Brien","year":"2017","unstructured":"O\u2019Brien M, Burke T, Heverin M, Vajda A, McLaughlin R, Gibbons J, et al. Clustering of neuropsychiatric disease in first-degree and second-degree relatives of patients with amyotrophic lateral sclerosis. JAMA Neurol. 2017;74:1425\u201330.","journal-title":"JAMA Neurol"},{"issue":"Pt 1","key":"133_CR138","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/aws307","volume":"136","author":"AC McKee","year":"2013","unstructured":"McKee AC, Stern RA, Nowinski CJ, Stein TD, Alvarez VE, Daneshvar DH, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013;136(Pt 1):43\u201364.","journal-title":"Brain"},{"key":"133_CR139","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1523\/JNEUROSCI.2711-16.2017","volume":"37","author":"M Kazmierczak","year":"2017","unstructured":"Kazmierczak M, Kazmierczak P, Peng AW, Harris SL, Shah P, Puel J-L, et al. Pejvakin, a candidate stereociliary rootlet protein, regulates hair cell function in a cell-autonomous manner. J Neurosci. 2017;37:3447\u201364.","journal-title":"J Neurosci"},{"key":"133_CR140","doi-asserted-by":"crossref","first-page":"jcs206730","DOI":"10.1242\/jcs.206730","volume":"131","author":"DK Jones","year":"2018","unstructured":"Jones DK, Johnson AC, Roti Roti EC, Liu F, Uelmen R, Ayers RA, et al. Localization and functional consequences of a direct interaction between TRIOBP-1 and hERG\/KCNH2 proteins in the heart. J Cell Sci. 2018;131:jcs206730.","journal-title":"J Cell Sci"},{"key":"133_CR141","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/bioinformatics\/btn195","volume":"24","author":"T Ishida","year":"2008","unstructured":"Ishida T, Kinoshita K. Prediction of disordered regions in proteins based on the meta approach. Bioinformatics. 2008;24:1344\u20138.","journal-title":"Bioinformatics"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0133-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0133-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0133-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T20:58:46Z","timestamp":1684616326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-018-0133-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,8]]},"references-count":141,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["133"],"URL":"https:\/\/doi.org\/10.1038\/s41380-018-0133-2","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,8]]},"assertion":[{"value":"31 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}